Sentences with phrase «for more dividend»

Glad to see you hitting your goal and we've still got plenty of time left in the year for more dividend increases to be announced!

But it can turn out be a buyer opportunity for more dividend stocks as opposed to selling, as long as you are mentally prepared.

Investors are hoping that cash is used for more dividends and buybacks, but a safer bet could be on another round of merger mania.

Not exact matches

Increased marketing automation will pay dividends for consumers, too, who are more likely to see relevant ads and feel as though brands care about their interests.

The company's management (for more, see our feature on Costco in the Dec. 15 issue of Fortune) and history of earnings growth earn rapturous reviews from Don Kilbride of Wellington Management, who oversees Vanguard's Dividend Growth Fund: «I could talk forever about Costco.»

«But in fact, the new «activist» investors pushed for seats on boards and pressured management into policies that were viewed as more «shareholder - friendly» — meaning friendlier to short - term investors — including increasing dividends and buyouts.»

More importantly, though, dividends and capital gains tend to go up and down with the economy, which has translated in wild tax revenue swings for states that rely heavily on personal income taxes.

It also means that over the next year, Apple will be paying more back in dividends than any other publicly traded company, beating out oil giant Exxon Mobil for the position, according to Howard Siliverblatt, veteran market watcher and senior index analyst at S&P Dow Jones Indices.

If these increases occur, this will be the sixth consecutive year in which Telus has increased its divided by 10 per cent or more in what Entwistle calls a multi-year dividend growth program, which remains a priority for the company.

The WisdomTree U.S. Quality Dividend Growth Index, for example, beat the S&P 500 Index by more than 550 basis points in 2017, and we continue to prefer the company and sector tilts within this Index relative to the broader market.

Now share buybacks aren't necessarily a bad thing, and in fact are Warren Buffett's preferred method for returning cash to shareholders — as opposed to dividends — because they give management more flexibility.

Buffett is right that, for most of his stock - picking history, shareholders have likely been better off leaving their money in his care rather than siphoning the cash into their own accounts by way of dividends: Since 1965, Berkshire Hathaway stock has delivered annualized returns of nearly 21 %, more than double the S&P 500.

Barclays also announced a restoration of its dividend to 6.5 pence per share for 2018, more than double the last year's full - year dividend of 3 pence.

Barclays announced a restoration of its dividend to 6.5 pence per share for 2018, more than double the last year's full - year dividend.

Warren Buffett, No. 3 on Forbes» list of the world's richest people and most prominent among the low - tax dissenters, wrote an op - ed in The New York Times arguing that, in concert with budget cuts, Washington should raise taxes — especially on dividends and capital gains — for those earning upwards of US$ 1 million a year and even more on the 8,000 or so Americans making $ 10 million and up.

The stocks that hedge funds have largely ignored tend to be much larger than the hotels, have less debt, grow earnings more slowly but consistently, and pay bigger dividends (an average yield of nearly 3 % for the S&P 500 constituents, compared with 2 % for the index overall).

For example, Pimco's Dividend and Income Builder Fund has more than 90 % invested in equities.

«If you are just buying income and not paying attention to the valuations, you are probably taking on more risk than you bargained for,» says Brad Kinkelaar, head of the dividend team at Pimco.

These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).

The reemergence of a prevailing consensus might be positive if it means more predictable earnings growth and more stable dividends for an otherwise schizophrenic sector.

An above - average dividend yield (the MSCI Canada Energy Index is yielding an annualized dividend of 3.6 % versus 2.9 % on the overall MSCI Canada index, according to Bloomberg data as of July 31, 2017) and lower price volatility could make energy a more attractive sector for income - seeking investors in a low yield world.

The price to cash flow ratio would provide a better idea of the amount of money available to management for further research and development, marketing support, debt reduction, dividends, share repurchases, and more.

A single share of Coke purchased for $ 40 in the IPO back in 1919 would have grown to more than $ 5,000,000 with dividends reinvested by the time this article was originally published on July 31st, 2006.

«Though Apple recently commenced paying a common dividend and initiated a nominal share repurchase program, we believe that there is much more that the Board should do for shareholders.

Thus, there is much activity in this area, and all this allows us to be sure that Tenaris goods are going to me in demand for at least a year more, which may further boost earnings and dividend gains.

You can quickly retrieve information on your account holdings and history, view and download frequently used forms and process many transactions such as, sale of shares, address changes, enroll in the dividend reinvestment plan, sign up for direct deposit of dividends and more.

For example, some investors may have taken on more risk in their portfolios in recent years by moving into lower - quality bonds or dividend stocks, in an attempt to generate additional yield.

More conservative investors could opt for higher dividend, lower volatility ETFs like Claymore S&P / TSX Canadian Dividend ETF (CDZdividend, lower volatility ETFs like Claymore S&P / TSX Canadian Dividend ETF (CDZDividend ETF (CDZ / TSX).

Even more so, I am excited to see my dividend income for Q4 - 2017 as I will have two distributions from many of my funds.

Annualized, that is about 8.6 % and more than enough to make up for the miserly dividends.

(Reuters)- Murphy Oil Corp (MUR.N) said it will spin off its smaller retail gasoline business in the United States, review options for other assets, pay a special dividend and buy back shares as it seeks to return more cash to shareholders.

Now that you're no longer getting dividends for free, have you considered moving to more growth stocks and less dividend building in your taxable funds?

The thing is, the alternative to dividend investing — investing for total return — will get you even more money than a dividend investing strategy ever will.

The predictability of monthly dividends is a comforting factor that has become a more prominent tactic for many income - oriented...

Believe it or not, you could be paying up to 36 times (or more) for a dividend - focused fund compared to a low - cost broadly diversified index fund.

If I wasn't so heavily weighted in O (accounts for 23 % of my projected annual dividend income), I'd probably pick up at some more shares here in the low $ 40's.

For more information about this raise, read my post on Dividend increase Unilever 2018.

Thanks for wanting to learn more about my Dividend Stock Portfolio Tracker on Google Sheets.

As for dividend taxes from foreign stocks, still need to do more research here.

Simply Safe Dividends gives ALL of the criteria items I need in just one place in both numerical as well as graphical format for each stock: dividend yield, P / E ratio, Dividend Safety & Growth scores, EPS & FCF payout ratios, ex-dividend dates, pay dates, 1 -, 3 -, 5 -, and 10 - year dividend growth rates, dividend payout history, return on equity, adividend yield, P / E ratio, Dividend Safety & Growth scores, EPS & FCF payout ratios, ex-dividend dates, pay dates, 1 -, 3 -, 5 -, and 10 - year dividend growth rates, dividend payout history, return on equity, aDividend Safety & Growth scores, EPS & FCF payout ratios, ex-dividend dates, pay dates, 1 -, 3 -, 5 -, and 10 - year dividend growth rates, dividend payout history, return on equity, adividend dates, pay dates, 1 -, 3 -, 5 -, and 10 - year dividend growth rates, dividend payout history, return on equity, adividend growth rates, dividend payout history, return on equity, adividend payout history, return on equity, and more.

I began seriously investing for dividend income... more

I began seriously investing for dividend income around 2007 when my business at the time was literally falling off a cliff, as most of the world was starting too as well, when my need for another income stream became more apparent.

For those who do follow this blog more consistently I'm sure you noticed I haven't be really updating my portfolio nor have I been keeping up with my dividends / assets as well as I normally do.

I've also included a Google Docs list of all the companies in the list with their streak length, but the excel spreadsheets provided above have a lot more information like the dividend yield, average highest yield for 3, 5 and 10 years, the past 10 years worth of dividends, and lots of other stock information.

Expected Dividend Increases in April for my Vrijheid Fonds If you have visited Polliesdividend more often, you know that I track the dividend increases of the companies in myVrijheiDividend Increases in April for my Vrijheid Fonds If you have visited Polliesdividend more often, you know that I track the dividend increases of the companies in myVrijheidividend increases of the companies in myVrijheid Fonds.

This would make bonds more attractive and diminish appetite for dividend stocks overall.

(In fact, had you purchased a single share for $ 40 in that 1919 IPO, and reinvested your dividends, it would now be worth more than $ 10 million.

Financially parasitized companies use corporate income to buy back their stock to support its price — and hence, the value of stock options that financial managers give themselves — and borrow yet more money for stock buybacks or simply to pay out as dividends.

Fortunately, that should be changing going forward as my capital should be freed up a bit more for allocation to my dividend growth investments.

A single share bought for $ 40 in the IPO back in 1919 is now worth more than $ 10,000,000 with dividends reinvested.